Astrazeneca denies vaccine delivery shortfall to EU, Italy – paper
Published by linker 5
Posted on February 25, 2021

Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.
Published by linker 5
Posted on February 25, 2021

MILAN (Reuters) – AstraZeneca will deliver 180 million COVID-19 vaccines to Europe in the second quarter, of which 20 million to Italy, the head of its Italian unit was quoted as saying on Thursday, dismissing reports of a possible shortfall.
Lorenzo Wittum, the CEO and chairman of Astrazeneca in Italy, told daily Il Corriere della Sera in an interview Italy would receive more than 5 million shots by the end of March, fewer than the 8 million previously agreed, leading to a total of 25 million doses by June.
Reuters reported on Tuesday, citing an EU official directly involved in talks with the Anglo-Swedish drugmaker, that AstraZeneca expected to deliver less than half the COVID-19 vaccines it was contracted to supply the European Union in the second quarter.
Wittum also said the pharmaceutical company was considering the possibility of administering a third dose and was working on new versions of the vaccine.
(Reporting by Maria Pia Quaglia, editing by Agnieszka Flak)